Sidley Austin LLP has advised Immunovant, Inc. Latham & Watkins LLP has advised the underwriter. Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company focused on developing...
Immunovant Raises $550 Million in Common Stock Offering
Abivax Completes $747.5 Million Public Offering on Nasdaq
Dechert has advised Abivax. Cooley LLP has advised Abivax on U.S. law. Latham & Watkins LLP and Gide Loyrette Nouel A.A.R.P.I. have advised the underwriters. French...